Bailer U, de Zwaan M, Schüssler P, el-Giamal N, Strnad A, Lennkh C, Kasper S
Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien, Osterreich.
Wien Klin Wochenschr. 2000 Oct 27;112(20):865-75.
Even though there is no convincing evidence that eating disorders in general are on the rise, there has been an enormous increase in "treated" cases of patients with eating disorders. This review will cover important aspects of diagnosis and treatment of eating disorders. Psychotherapeutical and pharmacological treatment strategies in anorexia and bulimia nervosa will be discussed. For both eating disorders, psychotherapy is the treatment of choice. Drugs with a serotonergic function, e.g. serotonin-reuptake-inhibitors (SSRI), have demonstrated significant results in the treatment of bulimia nervosa and eating disorders with comorbid depression. In clinical practice "treatment packages" are offered because of the complexity of the disorders. The paper also deals with medical complications of eating disorders, motivational interviewing in anorexia nervosa and treatment with self-help manuals in bulimia nervosa.
尽管没有确凿证据表明饮食失调总体上呈上升趋势,但饮食失调患者的“已治疗”病例却大幅增加。本综述将涵盖饮食失调诊断和治疗的重要方面。将讨论神经性厌食症和神经性贪食症的心理治疗和药物治疗策略。对于这两种饮食失调症,心理治疗是首选治疗方法。具有血清素能功能的药物,如血清素再摄取抑制剂(SSRI),已在治疗神经性贪食症和伴有共病抑郁症的饮食失调症方面显示出显著效果。在临床实践中,由于这些疾病的复杂性,会提供“治疗套餐”。本文还探讨了饮食失调的医学并发症、神经性厌食症中的动机访谈以及神经性贪食症中自助手册的治疗方法。